GSK to buy RAPT Therapeutics for $2.2 billion
Reuters·2026-01-20 07:11Group 1 - GSK announced the acquisition of U.S.-based RAPT Therapeutics for $2.2 billion [1]
Reuters·2026-01-20 07:11 Reuters·2026-01-20 07:11 Reuters·2026-01-20 07:11Group 1 - GSK announced the acquisition of U.S.-based RAPT Therapeutics for $2.2 billion [1]